Related Articles
NF-κB inhibitor reverses temozolomide resistance in human glioma TR/U251 cells
BKM120 sensitizes C6 glioma cells to temozolomide via suppression of the PI3K/Akt/NF‑κB/MGMT signaling pathway
Association between SOX9 and CA9 in glioma, and its effects on chemosensitivity to TMZ
MicroRNA‑9 enhances chemotherapy sensitivity of glioma to TMZ by suppressing TOPO II via the NF‑κB signaling pathway
miR‑146b‑5p suppresses glioblastoma cell resistance to temozolomide through targeting TRAF6